Javascript must be enabled to continue!
The Impact of the Interaction between Intestinal Flora and Intestinal Wall Immune Microenvironment on Ulcerative Colitis
View through CrossRef
Ulcerative colitis (UC) is a chronic, non-specific inflammatory disease of the intestine with an unknown etiology. The primary clinical manifestations include recurrent abdominal pain, diarrhea, mucus and purulent discharge, bloody stools, and tenesmus. Experts generally agree that the onset of this disease is primarily associated with factors such as intestinal flora, dietary composition, genetics, immunity, infections, and systemic inflammation. The intestinal flora constitutes the largest microecological system within the human body, consisting of a vast array of microorganisms that interact dynamically with the immune cells located in the intestinal wall. This interaction is crucial for maintaining a balance with the intestinal mucosa. The intestinal flora plays a significant role in the development of the immune system, sustaining normal immune function, and cooperatively countering the invasion of pathogenic bacteria. Alterations in the composition of the intestinal flora can influence the equilibrium between intestinal tolerance and immunity. Research has demonstrated that the disease process in UC patients is closely linked to disturbances in the structure of the intestinal bacterial flora,and symptoms can be significantly alleviated following the transplantation of normal flora. Therefore,Modulating the structure of the intestinal microbiota may serve as an effective strategy for treating ulcerative colitis (UC). This article examines the relationship between intestinal flora and intestinal wall immunity in the context of UC, while also exploring novel approaches for its treatment.
Al-Kindi Center for Research and Development
Title: The Impact of the Interaction between Intestinal Flora and Intestinal Wall Immune Microenvironment on Ulcerative Colitis
Description:
Ulcerative colitis (UC) is a chronic, non-specific inflammatory disease of the intestine with an unknown etiology.
The primary clinical manifestations include recurrent abdominal pain, diarrhea, mucus and purulent discharge, bloody stools, and tenesmus.
Experts generally agree that the onset of this disease is primarily associated with factors such as intestinal flora, dietary composition, genetics, immunity, infections, and systemic inflammation.
The intestinal flora constitutes the largest microecological system within the human body, consisting of a vast array of microorganisms that interact dynamically with the immune cells located in the intestinal wall.
This interaction is crucial for maintaining a balance with the intestinal mucosa.
The intestinal flora plays a significant role in the development of the immune system, sustaining normal immune function, and cooperatively countering the invasion of pathogenic bacteria.
Alterations in the composition of the intestinal flora can influence the equilibrium between intestinal tolerance and immunity.
Research has demonstrated that the disease process in UC patients is closely linked to disturbances in the structure of the intestinal bacterial flora,and symptoms can be significantly alleviated following the transplantation of normal flora.
Therefore,Modulating the structure of the intestinal microbiota may serve as an effective strategy for treating ulcerative colitis (UC).
This article examines the relationship between intestinal flora and intestinal wall immunity in the context of UC, while also exploring novel approaches for its treatment.
Related Results
P0050 4-Octyl Itaconate Protects Against Colitis by Modulating Neutrophil Function and Enhancing Intestinal Epithelial Barrier Integrity
P0050 4-Octyl Itaconate Protects Against Colitis by Modulating Neutrophil Function and Enhancing Intestinal Epithelial Barrier Integrity
Abstract
Background
Inflammatory bowel disease (IBD) is a complex gastrointestinal condition marked by immune system dysfunction...
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Ulcerative colitis is a multifactorial, chronic inflammatory disease of the bowel that can cause physical, social and emotional injury to the patient. While perhaps not always maki...
P0100 Role of Ethyl Pyruvate on Large Intestinal Inflammatory and Oxidative Markers in TNBS-Induced Colitis
P0100 Role of Ethyl Pyruvate on Large Intestinal Inflammatory and Oxidative Markers in TNBS-Induced Colitis
Abstract
Background
Ethyl pyruvate (EP), with anti-inflammatory and antioxidant effects, has shown therapeutic potential ...
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Background: Ulcerative colitis is a chronic idiopathic inflammatory bowel disease (IBD) characterized by intestinal inflammation confined to the superficial mucosal layer. Mesalazi...
Anemia in Patients with Ulcerative Colitis in Remission: A Cross-Sectional Study from Pakistan
Anemia in Patients with Ulcerative Colitis in Remission: A Cross-Sectional Study from Pakistan
Background and Aim: Anemia is an extra intestinal manifestation of inflammatory bowel disease that frequently causes complications. In inflammatory bowel disease (IBD) such as ulce...
Dual-pathway mechanisms of plant-derived polysaccharides in ulcerative colitis: integrative roles of microbiota modulation, immune regulation, and barrier restoration
Dual-pathway mechanisms of plant-derived polysaccharides in ulcerative colitis: integrative roles of microbiota modulation, immune regulation, and barrier restoration
Chronic inflammation of the colon has been described as an inflammatory condition of the colon that is characterized by recurring flare-ups of the disease (ulcerative colitis). Ulc...
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Abstract
Background
Ulcerative colitis (UC) belongs inflammatory disease with chronic and relapsing characterizations and increa...
Ulcerative Colitis Ocular Manifestations in Patients Admitted to a Peshawar Tertiary Care Hospital
Ulcerative Colitis Ocular Manifestations in Patients Admitted to a Peshawar Tertiary Care Hospital
Objective: This study aimed to see how common ocular symptoms of ulcerative colitis were in patients hospitalized in a tertiary care hospital in Peshawar. Methodology: At Hayatabad...

